Until 1984 only aspirin and acetaminophen shared the lucrative nonprescription pain-reliever market. In 1984, however, ibuprofen was expected to account for fifteen percent of all nonprescription pain-reliever sales.On that basis business experts predicted for 1984 a corresponding fifteen percent decrease in the combined sales of aspirin and acetaminophen.